FOLFOXIRI-Bev as first-line treatment in patients with metastatic colorectal cancer: a systematic review of RCT

被引：0
|
作者：
Luih, B. Stephanie [1 ]
Samudra, E. [1 ]
Suwongto, G. Sonia [1 ]
Glory, H. [1 ]
Colfoort, K. [1 ]
Wirajaya, P. [1 ]
Kurniawan, A. [1 ]
机构：
[1] Pelita Harapan Univ, Sch Med Pelita Harapan, Banten, Indonesia
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.588
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO42-1
引用
收藏
页码：S1349 / S1350
页数：2
相关论文
共 50 条
  • [21] First-line treatment strategies for elderly patients with metastatic colorectal cancer
    Meulenbeld, Hielke J.
    Creemers, Geert-Jan
    DRUGS & AGING, 2007, 24 (03) : 223 - 238
  • [22] First-Line Systemic Chemotherapy with Folfoxiri Followed by Radical Surgical Resection of Metastases for the Treatment of Unresectable Metastatic Colorectal Cancer Patients
    Vasile, Enrico
    Masi, Gianluca
    Loupakis, Fotios
    Cupini, Samanta
    Baldi, Giacomo Giulio
    Fornaro, Lorenzo
    Stasi, Irene
    Salvatore, Lisa
    Falcone, Alfredo
    PLATINUM AND OTHER HEAVY METAL COMPOUNDS IN CANCER CHEMOTHERAPY: MOLECULAR MECHANISMS AND CLINICAL APPLICATIONS, 2009, : 285 - 293
  • [23] CETUXIMAB FOR THE FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ubago, R.
    Castillo, M. A.
    Flores, S.
    Rodriguez, R.
    Beltran, C.
    VALUE IN HEALTH, 2011, 14 (07) : A433 - A434
  • [24] Cetuximab for the first-line treatment of metastatic colorectal cancer
    Meads, C.
    Round, J.
    Tubeuf, S.
    Moore, D.
    Pennant, M.
    Baylis, S.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 1 - 8
  • [25] Optimizing the first-line treatment for metastatic colorectal cancer
    Cherri, Sara
    Oneda, Ester
    Zanotti, Laura
    Zaniboni, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [26] Optimizing the first-line treatment for metastatic colorectal cancer
    Ciardiello, Davide
    Petrillo, Angelica
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [27] Efficacy of bevacizumab in first-line treatment of metastatic colorectal cancer: A systematic review and meta-analysis
    Baraniskin, Alexander
    Buchberger, Barbara
    Pox, Christian
    Graeven, Ulli
    Holch, Julian W.
    Schmiegel, Wolff
    Heinemann, Volker
    EUROPEAN JOURNAL OF CANCER, 2019, 106 : 37 - 44
  • [28] Cost-effectiveness analysis of FOLFOXIRI/FOLFOXIRI and mFOLFOX6/FOLFIRI treatment in first-line and second-line chemotherapy for metastatic colorectal cancer
    Li, Xianglian
    Bao, Jianan
    Ma, Jingjing
    BMJ OPEN, 2025, 15 (03):
  • [29] Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies
    Dagher, Mohammed
    Sabido, Meritxell
    Zoellner, York
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2019, 145 (08) : 2105 - 2114
  • [30] Effect of age on the effectiveness of the first-line standard of care treatment in patients with metastatic colorectal cancer: systematic review of observational studies
    Mohammed Dagher
    Meritxell Sabidó
    York Zöllner
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2105 - 2114
12345